Jayapal Reddy Mallareddy
5PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 25, 2024
The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax.Alexandria P Eiken, Elizabeth Schmitz, Erin M Drengler
|Apr 30, 2024
Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects.Alexandria P Eiken, Audrey L Smith, Sydney A Skupa
|Apr 27, 2022
Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growth.John Victor Napoleon, Satish Sagar, Sydney P Kubica
|Nov 13, 2021
Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase.Sandeep Rana, Jayapal Reddy Mallareddy, Sarbjit Singh
Pageof 1
Frequent Collaborators
5 joint publications
Amarnath Natarajan
3 joint publications
Sandeep Rana
2 joint publications
Lidia Boghean
2 joint publications
Dalia El-Gamal
2 joint publications
Sarbjit Singh
2 joint publications
Sydney A Skupa
2 joint publications
Audrey L Smith
1 joint publications
Smit Kour
1 joint publications
Smitha Kizhake
1 joint publications
Gloria E O Borgstahl
